7 May 2021 |
| 07:00-18:30 | | Registration |
| 07:20-07:50 | | Breakfast for Working Group attendees |
| 07:50-09:50 | | Working Group - Turner Syndrome (TS) |
| 07:50-09:50 | | Working Group - Gender Incongruence (GI) |
| 07:50-09:50 | | Working Group - Paediatric and Adolescent Gynaecology (PAG) |
| 07:50-09:50 | | Working Group - Diabetes Technology (DT) |
| 07:50-09:50 | | Working Group - Bone and Growth Plate (BGP) |
| 07:50-09:50 | | Working Group - Obesity (OWG) |
| 07:50-09:50 | | Working Group - Disorders of Sex Development (DSD) |
| 09:50-10:20 | | Tea & coffee break |
| 10:20-10:35 | | Opening CeremonyHall A |
| 10:35-11:05 | | Plenary 1 - A Kiss before sex |
| 10:35 | PL1 | A Kiss before sexWaljit Dhillo (London, UK) |
| 11:05-11:35 | | Awards 1 |
| 11:45-13:15 | | Symposium 1 - Endocrine Hypertension - Aetiology directed management |
| 11:45 | S1.1 | Pathogenesis of familial and sporadic hyperaldosteronism: new concepts involving Ion channelsMartin Reincke (University Hospital Munich, Munich, Germany) |
| 12:15 | S1.2 | Pheochromocytomas and paragangliomas: from genetic diversity to targeted therapiesKarel Pacak (USA) |
| 12:45 | S1.3 | Clinical, genetic, and structural basis of apparent mineralocorticoid excess due to 11β-hydroxysteroid dehydrogenase type 2 deficiencyMabel Yau (The Mount Sinai Hospital, New York, USA) |
| 11:45-13:15 | | Symposium 2 - Recent Breakthroughs in our understanding of Calcium & Phosphate Homeostasis |
| 11:45 | S2.1 | TBC |
| 12:15 | S2.2 | Phosphate toxicity: focus on medial vascular calcificationJakob Voelkl (Austria) |
| 12:45 | S2.3 | Calciotropic and non-calciotropic roles of the calcium sensing receptorDaniela Riccardi (UK) |
| 11:45-13:15 | | Symposium 3 - Bone formation: The growth plate and beyond |
| 11:45 | S3.1 | Epigenetic regulation of the growth plateJulian Lui (National Institute of Child Health and Human Development, USA) |
| 12:15 | S3.2 | Growth plate: new insights in the origin and function of the growth plateAndrei Chagin (Solna, Sweden) |
| 12:45 | S3.3 | The osteocyte: translating biomechanics into endocrine signalsAlex Robling (USA) |
| 11:45-13:15 | | Symposium 4 - Optimising the management of thyroid disorders |
| 11:45 | S4.1 | Prophylactic thyroidectomy in Multiple Endocrine NeoplasiaTom Kurzawinski (University College London Hospitals NHS Foundation Trust, London, UK) |
| 12:15 | S4.2 | Novel genes implicated in thyroid dysfunctionNadia Schoenmakers (Cambridge, UK) |
| 12:45 | S4.3 | Congenital hypothyroidism ERN guidelinesMichel Polak (Paris, France) |
| 11:45-13:15 | | Symposium 5 - Epigenetics in health and disease |
| 11:45 | S5.1 | Maternal obesity and offspring healthRebecca Reynolds (UK) |
| 12:15 | S5.2 | Epigenetics, imprinting and growthKaren Temple (UK) |
| 12:45 | S5.3 | Role of Epigenetics in endocrine disruption of prenatal development Aurore Gely-Pernot (France) |
| 13:15-14:30 | | Lunch, poster tours & exhibition |
| 13:25-14:25 | | Satellite Symposia |
| 14:30-15:00 | | Rapid Communications 3 |
| 14:30-15:00 | | Rapid Communications 2 |
| 14:30-15:00 | | Rapid Communications 1 |
| 14:30-15:15 | | Meet The Expert 1.1 |
| 14:30 | MTE1.1 | Thyroid hormone resistance syndromesKrishna Chatterjee (Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK) |
| 14:30-15:15 | | Meet The Expert 2.1 |
| 14:30 | MTE2.1 | Management of a child with pituitary adenomaMarianne Andersen (Odense University Hospital, Odense, Denmark) |
| 14:30-16:00 | | Novel Advances |
| 14:25 | NA1 | Gene therapyMarianne Delville (France) |
| 15:00-16:00 | | Free Communications 1 |
| 15:00-16:00 | | Free Communications 2 |
| 15:00-16:00 | | Free Communications 3 |
| 16:00-16:25 | | Tea & coffee break |
| 16:25-16:55 | | Plenary 2 - From the 100,000 Genomes Project to a new NHS genomic medicine service |
| 16:25 | PL2 | From the 100,000 Genomes Project to a new NHS genomic medicine serviceSian Ellard (UK) |
| 16:55-18:25 | | How Do I... (Session 1) |
| 14:30 | HDI1.1 | Treat non-classic CAH?Naomi Weintrob (Tel Aviv University, Kfar Saba, Israel) |
| 15:00 | HDI1.2 | Test gonadal function in neonates and infantsJorma Toppari (University of Turku, Turku, Finland) |
| 15:30 | HDI1.3 | Treat female hypogonadism at the time of transitionAnette Pedersen (University of Copenhagen , Copenhagen , Denmark) |
| 16:55-17:25 | | Rapid Communications 5 |
| 16:55-17:25 | | Rapid Communications 4 |
| 17:10-17:55 | | Meet The Expert 3.1 |
| 17:10 | MTE3.1 | Management of a child with post-neurosurgical hyponatraemiaSøren Rittig (Aarhus University , Aarhus, Denmark) |
| 17:10-17:55 | | Meet The Expert 4.1 |
| 17:10 | MTE4.1 | Cystic Fibrosis-related diabetesAndrea Kelly (USA) |
| 17:10-18:10 | | Yearbook of Paediatric Endocrinology - YB 1 |
| 17:25-18:25 | | Free Communications 5 |
| 17:25-18:25 | | Free Communications 4 |
| 18:30-20:00 | | Satellite symposium |
8 May 2021 |
| 07:00-17:00 | | Registration |
| 08:00-08:30 | | Plenary 3 - Iodine deficiency: a public health issue |
| 08:00 | PL3 | Iodine deficiency: A public health issueMichael Zimmermann (ETH Zurich, Zurich, Switzerland) |
| 08:30-09:30 | | Yearbook of Paediatric Endocrinology - YB 2 |
| 08:40-09:25 | | Meet The Expert 6.1 |
| 08:40 | MTE6.1 | Autoimmune endocrinopathyEystein Husebye (University of Bergen, Bergen, Norway) |
| 08:40-09:25 | | Meet The Expert 5.1 |
| 08:40 | MTE5.1 | Management of MEN1 in children and adolescentsMaria Luisa Brandi (Florence, Italy) |
| 08:40-09:25 | | Meet The Expert 7.1 |
| 08:40 | MTE7.1 | Endocrine and osteoporosis management of boys with DMDLeanne Ward (Children’s Hospital of Eastern Ontario, Ontario , Canada) |
| 08:40-09:25 | | Meet The Expert 8.1 |
| 08:40 | MTE8.1 | Real-life diabetes management during exerciseAndrea Scaramuzza (Italy) |
| 08:40-09:25 | | Meet The Expert 1.2 |
| 08:40 | MTE1.2 | Thyroid Hormone Resistance syndromesKrishna Chatterjee (Wellcome-MRC Institute of Metabolic Science, University of Cambridge, Cambridge, UK) |
| 09:35-10:05 | | Rapid Communications 6 |
| 09:35-10:05 | | Rapid Communications 7 |
| 09:35-10:05 | | Rapid Communications 8 |
| 09:35-10:05 | | Rapid Communications 9 |
| 09:35-10:05 | | Rapid Communications 10 |
| 09:35-11:05 | | ERN |
| 10:05-11:05 | | Free Communications 6 |
| 10:05-11:05 | | Free Communications 7 |
| 10:05-11:05 | | Free Communications 8 |
| 10:05-11:05 | | Free Communications 9 |
| 10:05-11:05 | | Free Communications 10 |
| 11:05-11:35 | | Tea & coffee break |
| 11:35-12:05 | | Awards 2 |
| 12:05-12:35 | | Plenary 4 - Development of novel therapies for obesity |
| 12:05 | PL4 | Development of novel therapies for obesityMatthias Tschop (Germany) |
| 12:35-13:05 | | Awards 3 |
| 13:05-14:20 | | Lunch, poster tours & exhibition |
| 13:15-14:15 | | Satellite symposium |
| 14:00-16:00 | | GPED |
| 14:25-16:25 | | Working Group - Nursing and Allied Health (PENS) |
| 14:25-15:55 | | Symposium 6 - Hot Topics in Paediatric Endocrinology |
| 14:25 | S6.1 | Environmental obesogensLeonardo Trasande (USA) |
| 14:55 | S6.2 | New insights into sex differentiation and their clinical relevance to disorders of sex developmentHumphrey Yau (USA) |
| 15:25 | S6.3 | Vitamin D and male reproductionMartin Blomberg-Jensen (Denmark) |
| 14:25-15:55 | | Symposium 8 - Novel therapies in endocrinology |
| 14:25 | S8.1 | Setmelanotide in the treatment of rare obesity syndromesPeter Kühnen (University of Duisburg-Essen, Berlin, Germany) |
| 14:55 | S8.2 | Vosoritide in achondroplasiaRavi Savarirayan (Melbourne, Australia) |
| 15:25 | S8.3 | Coming soon: new drugs for treatment of youth with type 2 diabetesWilliam Tamborlane (Yale School of Medicine, New Haven, USA) |
| 14:25-15:25 | | Controversies 1 |
| 17:10 | CON1.1 | Should CGM be used in every child with diabetes? (AGAINST)Fergus Cameron (Australia) |
| 17:10 | CON1.2 | Should CGM be used in every child with diabetes? (FOR)Tadej Battelino (Slovenia) |
| 14:25-15:55 | | Symposium 10 - Pathways to improved diagnosis and management of hypothalamo-pituitary disorders |
| 15:25 | S10.1 | The role of the MAPK pathway in hypothalamo-pituitary axis development and diseaseCarles Gaston-Massuet (UK) |
| 15:55 | S10.2 | Delayed puberty: A genetic condition?Sasha Howard (London, UK) |
| 16:25 | S10.3 | Novel insights into the management of cranial diabetes and insipidusMohamad Maghnie (Italy) |
| 16:00-17:00 | | GPED AGM |
| 16:00-16:30 | | Plenary 5 - The transgender dilemma |
| 16:00 | PL5 | The transgender dilemmaStephen Rosenthal (USA) |
| 16:30-16:45 | | Tea & coffee break |
| 16:45-18:15 | | Satellite symposium |
| 18:15-19:15 | | ESPE Annual Business Meeting (ESPE members only) |
9 May 2021 |
| 07:00-18:00 | | Registration |
| 08:00-08:45 | | Meet The Expert 2.2 |
| 08:00 | MTE2.2 | Management of a child with pituitary adenomaMarianne Andersen (Odense University Hospital, Odense, Denmark) |
| 08:00-08:45 | | Meet The Expert 3.2 |
| 08:00 | MTE3.2 | Management of a child with post-neurosurgical hyponatraemiaSøren Rittig (Aarhus University , Aarhus, Denmark) |
| 08:00-08:45 | | Meet The Expert 4.2 |
| 08:00 | MTE4.2 | Cystic Fibrosis-related diabetesAndrea Kelly (USA) |
| 08:00-08:45 | | Meet The Expert 5.2 |
| 08:00 | MTE5.2 | Management of MEN1 in children and adolescentsMaria Luisa Brandi (University of Florence, Florence, Italy) |
| 08:00-09:00 | | Yearbook of Paediatric Endocrinology - YB 3 |
| 09:10-09:40 | | Rapid Communications 11 |
| 09:10-09:40 | | Rapid Communications 12 |
| 09:10-09:40 | | Rapid Communications 13 |
| 09:10-09:40 | | Rapid Communications 14 |
| 09:10-10:40 | | How Do I... (session 2) |
| 09:10 | HDI2.1 | Investigate the child with unexplained fracturesZulf Mughal (Al Jalila Children’s Specialty Hospital, Dubai , UAE) |
| 09:40 | HDI2.2 | Manage a patient with tall statureLars Sävendahl (Sweden) |
| 10:10 | HDI2.3 | Advise patients on insulin dosing for real mealsEwa Pankowska (Poland) |
| 09:40-10:40 | | Free Communications 11 |
| 09:40-10:40 | | Free Communications 14 |
| 09:40-10:40 | | Free Communications 13 |
| 09:40-10:40 | | Free Communications 12 |
| 10:40-11:10 | | Tea & coffee break |
| 11:10-11:40 | | Plenary 6 - The current state of epigenetic research in humans: promise and reality |
| 11:10 | PL6 | The current state of epigenetic research in humans: promise and realityJohn Greally (USA) |
| 11:40-12:10 | | Awards 4 |
| 12:10-12:40 | | Plenary 7 - Novel insights into weight regulation |
| 12:10 | PL7 | Novel insights into weight regulationSadaf Farooqi (Cambridge, UK) |
| 12:40-13:55 | | Lunch, poster tours & exhibition |
| 12:45-13:45 | | Satellite symposia |
| 13:55-14:55 | | Controversies 2 |
| 13:55 | CON2.1 | Should children with GHD be re-tested early eg as they start puberty, rather than wait until the final height is achieved? (FOR)Sandro Loche (Cagliari, Italy) |
| 13:55 | CON2.2 | Should children with GHD be re-tested early eg as they start puberty, rather than wait until the final height is achieved? (AGAINST)Jan-Maarten Wit (Willem-Alexander Children’s Hospital, Leiden, The Netherlands) |
| 13:55-14:55 | | Young Investigators |
| 14:00-14:45 | | Meet The Expert 6.2 |
| 14:00 | MTE6.2 | Autoimmune endocrinopathyEystein Husebye (University of Bergen, Bergen, Norway) |
| 14:00-14:45 | | Meet The Expert 7.2 |
| 14:00 | MTE7.2 | Endocrine and osteoporosis management of boys with DMDLeanne Ward (Children’s Hospital of Eastern Ontario, Ontario , Canada) |
| 14:00-14:45 | | Meet The Expert 8.2 |
| 14:00 | MTE8.2 | Real-life diabetes management during exerciseAndrea Scaramuzza (Unit of Pediatrics , Asola, Italy) |
| 14:55-15:25 | | Tea & coffee break |
| 15:25-16:55 | | Symposium 9 - Recent developments in congenital adrenal hyperplasia |
| 15:25 | S9.1 | Novel insights and long term outcomesWiebke Arlt (MRC Laboratory of Medical Sciences, London, UK) |
| 15:55 | S9.2 | Testis function and fertility issues in men with CAHNiels Jørgensen (Denmark) |
| 16:25 | S9.3 | Advances in the measurement of steroid hormonesStefan Wudy (Germany) |
| 15:25-16:55 | | Symposium 11 - Advances in the management of congenital hyperinsulinism |
| 15:25 | S11.1 | Defining genotype-phenotype correlations in Congenital HyperinsulinismSarah Flanagan (Exeter, UK) |
| 15:55 | S11.2 | Novel therapies in the treatment of Congenital HyperinsulinismDiva D. de Leon-Crutchlow (Philadelphia, USA) |
| 16:25 | S11.3 | A laparoscopic approach in patients with Congenital HyperinsulinismPaolo de Coppi (Great Ormond Street Hospital , London, UK) |
| 15:25-16:55 | | Symposium 12 - Novel technologies in the treatment of diabetes |
| 15:25 | S12.1 | Latest developments in closed loop technologyEmma Wilmot (UK) |
| 15:55 | S12.2 | Open APS – DIY closed loop systemsAlastair McLay (NHS East Midlands, Edinburgh, UK) |
| 16:25 | S12.3 | The use of big data and artificial intelligence in managing the therapy of people with T1DMMoshe Phillip (Israel) |
| 15:25-16:55 | | Symposium 7 - Endocrine consequences of childhood brain tumours |
| 14:25 | S7.1 | Paediatric Neurosurgery in the 21st CenturyConor Mallucci (British Paediatric Neurosurgery Research Group, UK) |
| 14:55 | S7.2 | Proton-beam Therapy for CNS tumours in childhoodDaniel Indelicato (USA) |
| 15:25 | S7.3 | Hypothalamic obesity in craniopharyngiomacHermann Müller (Ludwig Maximilian University of Munich, Munich, Germany) |
| 17:00-17:15 | | International Award & President Poster Award |
| 17:15-17:45 | | Plenary 8 - The long-term effects of adolescent obesity |
| 17:15 | PL8 | The long-term effects of adolescent obesityThomas Reinehr (Germany) |
| 17:45-18:00 | | Closing Ceremony |